Results 141 to 150 of about 423,879 (287)

A prospective clinical study on the efficacy and safety of specific uric acid adsorption hemoperfusion in removing serum uric acid from patients with refractory gout

Zhongguo shuxue zazhi
[Objective] To evaluate the efficacy and safety of the single-use hemoperfusion device (UA230) in treating refractory gout (RG) via plasma perfusion. [Methods] Thirty-four RG patients aged 18-65 years were recruited and randomly divided into a control ...
LI Ying, YANG Yuanming, JING Zhongcui, LIU Jiao, JIANG Dandan, YU Shanshan, WANG Haiyan   +6 more
doaj   +1 more source

Bidirectional Regulation of NLRP3 Inflammasome and Mitochondrial Quality Control in Sepsis: Mechanisms and Therapeutic Implications

Mediators of Inflammation, Volume 2026, Issue 1, 2026.
Characterized by its capacity to induce organ failure, sepsis constitutes a life‐threatening pathological state with high incidence and mortality rates. Current treatments primarily focus on antimicrobial therapy and organ support, lacking direct interventions targeting the restoration of cellular or organelle function.
Xiangxin Liao, Yixun Wang, Zhaohui Zhang, Xingguang Qu, Gaosheng Zhou, Laurent L′homme   +5 more
wiley   +1 more source

Treatment approaches and adherence to urate-lowering therapy for patients with gout

Patient Preference and Adherence, 2017
Thanda Aung,* Gihyun Myung,* John D FitzGerald Division of Rheumatology/Department of Internal Medicine, University of California, Los Angeles, Los Angeles, CA, USA *These authors contributed equally to this work Abstract: Gout is the most common ...
Aung T, Myung G, FitzGerald JD
doaj  

Managing blood pressure control in Asian patients: safety and efficacy of losartan. [PDF]

, 2014
published_or_final_versio
Cheung, BMY, Cheung, TT
core   +2 more sources

High-resolution ultrasound evaluation in the follow-up of treat to target urate-lowering therapy in gout: an observational study [PDF]

, 2020
Weijing Zhang, Di Zhao, Min Wu, Zhibin Jin, Huayong Zhang   +4 more
openalex   +1 more source

Letter to the editor regarding “urate‐lowering therapy for patients with gout on hemodialysis” [PDF]

, 2022
Yung‐Shun Tsai, Yung‐Heng Lee, Meng‐Yu Ko   +2 more
openalex   +1 more source

Epidemiology and management of gout in Taiwan: a nationwide population study [PDF]

, 2015
INTRODUCTION: Gout is the most common inflammatory arthritis worldwide and is the only type of chronic arthritis that potentially can be ‘cured’. However, data on gout incidence, prevalence and management, assessed at multiple time points in the same ...
Doherty, Michael, Grainge, Matthew J., Kuo, Chang-Fu, Luo, Shue-Fen, See, Lai-Chu, Yu, Kuang-Hui, Zhang, Weiya   +6 more
core   +1 more source

Guideline development for the management of gout: role of combination therapy with a focus on lesinurad

Drug Design, Development and Therapy, 2017
Graeme Jones,1 Elena Panova,1 Richard Day2 1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; 2University of New South Wales, Medicine, St Vincent’s Hospital, Sydney, NSW, Australia Abstract: The aim of this ...
Jones G, Panova E, Day R
doaj  

Treatment of Gout in Patients with CrCl ≤30 mL/min and/or on Hemodialysis: A Review

Rheumato
Gout is highly prevalent in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), owing to impaired uric acid excretion. However, treating gout in this population is challenging due to concerns about medication safety and ...
Fares Saliba, Omar Mourad, Jonathan Mina, Fadi Haddadin, Laurence Aoun, Shaza Almardini, Saif Abu-baker, Koushik Sangaraju, Gaetano Di Pietro, Daniel Gaballa, Suzanne El-sayegh   +10 more
doaj   +1 more source

OP0300 5-YEAR TRAJECTORIES OF URATE-LOWERING THERAPY AND IMPACT OF COLCHICINE ON CARDIOVASCULAR RISK: REAL-LIFE DATA ON 70,000+ PATIENTS [PDF]

, 2022
Augustin Latourte, A. Bellamine, R. Sigogne, Heath A.K., T. Bardin, M. Maravic, Pascal Richette   +6 more
openalex   +1 more source